Clinical trials
Suspended Phase 1 Immunoblastic Lymphadenopathy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 1 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 1 |
| Washington University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunoblastic Lymphadenopathy | 3 |
| Lymphoma, T-Cell, Peripheral | 3 |
| Enteropathy-Associated T-Cell Lymphoma | 2 |
| Lymphoma, Large-Cell, Anaplastic | 2 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Leukemia, Myeloid, Acute | 1 |
| Leukemia, Prolymphocytic, T-Cell | 1 |
| Lymphoma, Extranodal NK-T-Cell | 1 |
| Lymphoma, T-Cell | 1 |
| Lymphoma, T-Cell, Cutaneous | 1 |
Trials
Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.